High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early stage treatment effect using 3'-deoxy-3' [18F]fluorothymidine positron emission tomography

被引:0
|
作者
Makino, Akira [1 ,2 ]
Kume, Kyo [3 ]
Mori, Tetsuya [1 ]
Tsujikawa, Tetsuya [1 ]
Asai, Tatsuya [4 ]
Okazawa, Hidehiko [1 ,2 ]
Kiyono, Yasushi [1 ,2 ]
机构
[1] Univ Fukui, Biomed Imaging Res Ctr, 23-3 Matsuoka-Shimoaizuki, Eiheiji, Fukui 9101193, Japan
[2] Univ Fukui, Life Sci Innovat Ctr, 9-1 Bunkyo 3, Fukui, Fukui 9108507, Japan
[3] Wakasa Wan Energy Res Ctr, 64-52-1 Nagatani, Tsuruga, Fukui 9140192, Japan
[4] Univ Fukui, Grad Sch Engn, 9-1 Bunkyo 3, Fukui, Fukui 9108507, Japan
关键词
Positron emission tomography; 3'-Deoxy-3'-[F-18]fluorothymidine (F-18-FLT); Hypoxia; Particle beam therapy; IMAGING PROLIFERATION; IN-VIVO; RADIATION;
D O I
10.1007/s12149-023-01877-2
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective Compared with radiation therapy using photon beams, particle therapies, especially those using carbons, show a high relative biological effectiveness and low oxygen enhancement ratio. Using cells cultured under normoxic conditions, our group reported a greater suppressive effect on cell growth by carbon beams than X-rays, and the subsequent therapeutic effect can be predicted by the cell uptake amount of 3'-deoxy-3'-[F-18]fluorothymidine (F-18-FLT) the day after treatment. On the other hand, a hypoxic environment forms locally around solid tumors, influencing the therapeutic effect of radiotherapy. In this study, the influence of tumor hypoxia on particle therapies and the ability to predict the therapeutic effect using F-18-FLT were evaluated.Methods Using a murine colon carcinoma cell line (colon 26) cultured under hypoxic conditions (1.0% O-2 and 5.0% CO2), the suppressive effect on cell growth by X-ray, proton, and carbon irradiation was evaluated. In addition, the correlation between decreased F-18-FLT uptake after irradiation and subsequent suppression of cell proliferation was investigated.Results Tumor cell growth was suppressed most efficiently by carbon-beam irradiation. F-18-FLT uptake temporarily increased the day after irradiation, especially in the low-dose irradiation groups, but then decreased from 50 h after irradiation, which is well correlated with the subsequent suppression on tumor cell growth.Conclusions Carbon beam treatment shows a strong therapeutic effect against cells under hypoxia. Unlike normoxic tumors, it is desirable to perform F-18-FLT positron emission tomography 2-3 days after irradiation for early prediction of the treatment effect.
引用
收藏
页码:112 / 119
页数:8
相关论文
共 30 条
  • [21] Noninvasive assessment of cell proliferation in ovarian cancer using [18F] 3′deoxy-3-fluorothymidine positron emission tomography/computed tomography imaging
    Richard, Scott D.
    Bencherif, Badreddine
    Edwards, Robert P.
    Elishaev, Esther
    Krivak, Thomas C.
    Mountz, James M.
    DeLoia, Julie A.
    NUCLEAR MEDICINE AND BIOLOGY, 2011, 38 (04) : 485 - 491
  • [22] Predictive value of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography/computed tomography for outcome of carbon ion radiotherapy in patients with head and neck mucosal malignant melanoma
    Inubushi, Masayuki
    Saga, Tsuneo
    Koizumi, Mitsuru
    Takagi, Ryo
    Hasegawa, Azusa
    Koto, Masashi
    Wakatuki, Masaru
    Morikawa, Takamichi
    Yoshikawa, Kyosan
    Tanimoto, Katsuyuki
    Fukumura, Toshimitsu
    Yamada, Shigeru
    Kamada, Tadashi
    ANNALS OF NUCLEAR MEDICINE, 2013, 27 (01) : 1 - 10
  • [23] Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging
    Wang, Fu-Li
    Tan, Ye-Ying
    Gu, Xiang-Min
    Li, Tian-Ran
    Lu, Guang-Ming
    Liu, Gang
    Huo, Tian-Long
    CHINESE MEDICAL JOURNAL, 2016, 129 (24) : 2926 - 2935
  • [24] Monitoring Tumor Response After Histone Deacetylase Inhibitor Treatment Using 3'-Deoxy-3'-[18F]-fluorothymidine PET
    Chan, Pei-Chia
    Wu, Chun-Yi
    Chou, Lin-Shan
    Ho, Chung-Hsien
    Chang, Chi-Wei
    Chiou, Shih-Hwa
    Lin, Wuu-Jyh
    Chen, Fu-Du
    Chang, C. Allen
    Hwang, Jeng-Jong
    Liu, Ren-Shyan
    Wang, Hsin-Ell
    MOLECULAR IMAGING AND BIOLOGY, 2015, 17 (03) : 394 - 402
  • [25] Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3′-Deoxy-3′-[18F]Fluorothymidine in Preclinical Models of Lung Cancer
    Schelhaas, Sonja
    Held, Annelena
    Wachsmuth, Lydia
    Hermann, Sven
    Honess, Davina J.
    Heinzmann, Kathrin
    Smith, Donna-Michelle
    Griffiths, John R.
    Faber, Cornelius
    Jacobs, Andreas H.
    CANCER RESEARCH, 2016, 76 (24) : 7096 - 7105
  • [26] Early Prediction of Nonprogression in Advanced Non-Small-Cell Lung Cancer Treated With Erlotinib By Using [18F]Fluorodeoxyglucose and [18F]Fluorothymidine Positron Emission Tomography
    Zander, Thomas
    Scheffler, Matthias
    Nogova, Lucia
    Kobe, Carsten
    Engel-Riedel, Walburga
    Hellmich, Martin
    Papachristou, Irini
    Toepelt, Karin
    Draube, Andreas
    Heukamp, Lukas
    Buettner, Reinhard
    Ko, Yon D.
    Ullrich, Roland T.
    Smit, Egbert
    Boellaard, Ronald
    Lammertsma, Adriaan A.
    Hallek, Michael
    Jacobs, Andreas H.
    Schlesinger, Andreas
    Schulte, Karin
    Querings, Silvia
    Stoelben, Erich
    Neumaier, Bernd
    Thomas, Roman K.
    Dietlein, Markus
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (13) : 1701 - 1708
  • [27] Response to the Letter to the Editor Regarding the Manuscript Entitled "Positron Emission Tomography with [18F]-3'-Deoxy-3'Fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: A Pilot Study"
    Dehdashti, Farrokh
    Grigsby, Perry W.
    Siegel, Barry A.
    MOLECULAR IMAGING AND BIOLOGY, 2013, 15 (06) : 786 - 787
  • [28] Response to the Letter to the Editor Regarding the Manuscript Entitled “Positron Emission Tomography with [18F]-3′-Deoxy-3′Fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: A Pilot Study”
    Farrokh Dehdashti
    Perry W. Grigsby
    Barry A. Siegel
    Molecular Imaging and Biology, 2013, 15 : 786 - 787
  • [29] Positron emission tomography in patients with breast cancer using 18F-3′-deoxy-3′-fluoro-L-thymidine (18F-FLT) -: a pilot study
    Been, LB
    Elsinga, PH
    de Vries, J
    Cobben, DCP
    Jager, PL
    Hoekstra, HJ
    Suurmeijer, AJH
    EJSO, 2006, 32 (01): : 39 - 43
  • [30] Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2-deoxy-2-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC)
    Fledelius, Joan
    Khalil, Azza Ahmed
    Hjorthaug, Karin
    Frokiaer, Jorgen
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2016, 60 (02) : 231 - 238